Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,20024/7 Wall Street • 09/27/26
FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areataPRNewsWire • 09/25/26
Eli Lilly Vs. Pfizer in 2027: One Is a Much Better Place to Park Your Pharmaceutical Capital Next Year24/7 Wall Street • 09/23/26
Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?The Motley Fool • 09/22/26
Novo's CagriSema Outshines Zepbound in Key Phase III Weight-Loss StudyZacks Investment Research • 09/22/26
His Bet On Home Depot Made Ken Langone A Billionaire. Now He Sees Eli Lilly Stock Hitting $2,00024/7 Wall Street • 09/22/26
Eli Lilly's Tough Month: One of The Biggest Global Banks Says 37% Gains Begin Soon24/7 Wall Street • 09/22/26
Eli Lilly (LLY) Increases Yet Falls Behind Market: What Investors Need to KnowZacks Investment Research • 09/21/26